by adminTorusBrand | Dec 13, 2017 | HempMeds Mexico, Press Releases
SAN DIEGO, Dec. 13, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, today announced that subsidiary HempMeds® Mexico generated the largest-ever revenue month in the history of the...
by adminTorusBrand | Nov 2, 2017 | HempMeds Mexico, Press Releases
SAN DIEGO, Nov. 2, 2017 /PRNewswire/ — Medical Marijuana, Inc.(OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that Raúl Elizalde, General Manager of subsidiary HempMeds® Mexico, was recently interviewed on Azteca...
by adminTorusBrand | Oct 26, 2017 | HempMeds, HempMeds Mexico, RaulWHO
Raul Elizalde to speak before WHO Expert Committee on Drug Dependence review of the psychoactivity of CBD. On November 6th, the World Health Organization’s (WHO) Thirty-Ninth meeting of the Expert Committee on Drug Dependence will begin a 5-day agenda set to determine...
by adminTorusBrand | Oct 26, 2017 | HempMeds, HempMeds Mexico, RaulWHO
Head of HempMeds® Mexico and vocal advocate for medical cannabis spearheaded cannabis reform in Mexico. A father’s love for his daughter will drive him to impossible heights. But watching her experience a seizure can make a father feel helpless as he stands by...
by adminTorusBrand | Oct 12, 2017 | HempMeds Mexico
[vc_row][vc_column][vc_column_text] Continued studies from Dr. Aguirre further reveal the advantages of a CBD treatment option for those suffering from seizures. Noted pediatric neurologist Dr. Carlos G. Aguirre-Velazquez today revealed the positive results of a...
by adminTorusBrand | Oct 12, 2017 | HempMeds Mexico, Press Releases
SAN DIEGO, Oct. 12, 2017 /PRNewswire/ — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the U.S., today announced that a recent clinical study conducted by renowned Mexico neurologist, Dr. Carlos G. Aguirre-Velazquez,...
